MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells-Reference-Cited by-同舟云学术

MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells

Published:2020-06 Issue: Volume:17 Page:496-507
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Bayne Robert S.,Puckett Shelby,Rodrigues Lindsey Ulkus,Cramer Scott D.,Lee Jingyun,Furdui Cristina M.,Chou Jeff W.,Miller Lance D.,Ornelles David A.,Lyles Douglas S.

Funder

National Institutes of Health

Department of Biochemistry, Wake Forest School of Medicine

NIH

Bioinformatics, Cancer Genomics, Cell Engineering, Flow Cytometry, and Proteomics and Metabolomics Shared Resources of the Wake Forest Baptist Comprehensive Cancer Center

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference73 articles.

1. Impaired interferon signaling is a common immune defect in human cancer;Critchley-Thorne;Proc. Natl. Acad. Sci. USA,2009

2. Going viral with cancer immunotherapy;Lichty;Nat. Rev. Cancer,2014

3. Interferon: current status and future prospects in cancer therapy;Wang;J. Interferon Cytokine Res.,2011

4. Interferons as inducers of apoptosis in malignant cells;Kotredes;J. Interferon Cytokine Res.,2013

5. Anti-metastatic functions of type 1 interferons: foundation for the adjuvant therapy of cancer;Ortiz;Cytokine,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer;Molecular Therapy: Oncology;2024-09

2. Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain–containing CAR;Science Signaling;2024-03-05

3. Recent advances and future perspectives in the therapeutics of prostate cancer;Experimental Hematology & Oncology;2023-09-22

4. State-dependent protein-protein interactions mediating 4-1BB CAR Signaling;2022-06-09

5. Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells;Molecular Therapy - Oncolytics;2021-09